[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Eve Sleep Plc LSE:EVE London Ordinary Share GB00BYWMFT51 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 2.85 193,281 08:13:04
Bid Price Offer Price High Price Low Price Open Price
2.70 3.00 2.90 2.85 2.85
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Personal Goods 25.22 -2.44 -0.75 8
Last Trade Time Trade Type Trade Size Trade Price Currency
16:00:09 O 20,000 2.88 GBX

Eve Sleep (EVE) Latest News

More Eve Sleep News
Eve Sleep Investors    Eve Sleep Takeover Rumours

Eve Sleep (EVE) Discussions and Chat

Eve Sleep Forums and Chat

Date Time Title Posts
27/11/202111:33EVE - King of Online Mattress Retailing Growing Fast Asos growth rates155
10/11/202111:16EVE covid infested matress clean up390
05/11/202110:17 eve Sleep PLC2,263
26/1/202112:57Evesham goes into administration6
21/1/202012:37Market Cap Ј33000 - a multibagger ?241

Add a New Thread

Eve Sleep (EVE) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Eve Sleep trades in real-time

Eve Sleep (EVE) Top Chat Posts

DateSubject
27/11/2021
08:20
Eve Sleep Daily Update: Eve Sleep Plc is listed in the Personal Goods sector of the London Stock Exchange with ticker EVE. The last closing price for Eve Sleep was 2.85p.
Eve Sleep Plc has a 4 week average price of 2.75p and a 12 week average price of 2.75p.
The 1 year high share price is 9.25p while the 1 year low share price is currently 2.75p.
There are currently 274,085,479 shares in issue and the average daily traded volume is 742,675 shares. The market capitalisation of Eve Sleep Plc is £7,811,436.15.
23/11/2021
07:40
clocktower: T101 Amazon did not make a profit for many years, as they invested in growth, while EVE may make a profit in the UK they maybe spending to grow the French market, but as they forecast their cash position will remain much the same. I assume that you do not have want me to post the fact once again from the RNS I previous posted. However thank you for posting you view as it provides any potential investors with food for thought. Once we get a trading update, we will see which view of the future of the business is reflected in the share price.
15/11/2021
08:39
clocktower: Nothing misleading at all, the facts about the cash etc are in the results posted in September. "-- Net cash as at 31 August 2021 increased to GBP5.9m, with minimal H2 outflow expected -- The UK&I is on-course to report a healthy positive marketing contribution for the second consecutive fullyear as the region moves towards profitability in 2022" Https://uk.advfn.com/stock-market/london/eve-sleep-EVE/share-news/Eve-Sleep-plc-Interim-Results/86117312
14/11/2021
17:12
clocktower: Net cash increased to £5.9m at 31 August 2021 and minimal H2 outflow expected. Sales were also looking like they are forging well ahead of 2019 figures. I acknowledge your concerns T101, so if I held your views I would not continue to hold the stock or add, as some have clearly been doing over the past weeks, not to forget Mike Lloyd buying 500 thousand share at around 3.14 recently, taking his holding to 1.5 million.Could you really be a buyer talking the stock down to pick up more cheap stock? I am sure all posters are grateful for your take on the BOD salaries and rewards for taking steps that should result in turning this into a successful enterprise and trust you will continue to post your warnings to prevent any naive investors from buying the shares without doing their own research, as they should always do before investing and risking funds they might not be able to afford to loose if everything goes the way you appear to believe it will. I highlighted what value this was when it was around 1.8p so since then there have been opportunities to sell at a considerable profit. There has been an introduction of lots of new sleep related products along with the recently added CBD products that will I am sure attract a lot of new clients to EVE.
13/11/2021
13:24
terminator101: Anyone curious as to how much the Directors have been creaming out of this lossmaking fluff, while the share price has gone from 17p to 3p in 3 years and 7p to 3 p in one year. Well for that amazing performance Tim Parfitt took £156,560 which was a nice 133% rise on his 2019 salary and Cheryl Calverley took £102,766 for 6 months, so the equivalent of over £200,000 a year. And thats without the nice little earner of millions of share options at an exercise price of 0.1p. Nice work if you can get it huh.
11/11/2021
16:13
clocktower: LOL DC - I wish but on a more serious note, I think the potential for a consolidation between the two would be in Simba's best interest, while the share price is low and EVE has a decent pile of cash and a business that is growing, as was demonstrated with the comments at the time of the last interims. Either way it is undervalued as the French side may be the growth sector this coming months, which would be a huge step. Since the change of CEO the business has made huge steps. She was the tonic the company needed. I checked and they are not selling the CBD products in France - are they legal there?
05/11/2021
10:08
david gruen: Debt Level: EVE is debt free. Reducing Debt: EVE has not had any debt for past 5 years. General Public 17.6% 47,967,249 shares Earnings have grown 27.4% per year over the past 5 years
05/11/2021
10:01
david gruen: eve Sleep plc Progressing the sleep wellness repositioning 05/11/2021 9:12am RNS Non-Regulatory TIDMEVE eve Sleep plc 05 November 2021 Eve Sleep plc ("eve" or the "Company") Progressing the sleep wellness repositioning: Update on new products eve Sleep, the direct to consumer sleep wellness brand operating in the UK, Ireland and France provides an update on its recent and pending product launches as part of its broader strategy to further evolve the business, and to become a favoured destination for all things better sleep for better mornings. As part of this strategy a collection of six eve branded CBD drops in Camomile and passionflower, and Ginkgo biloba and ginseng botanical extracts have today gone live on the evesleep.co.uk website. eve is also currently in discussions with a number of leading store based retailers who are interested in stocking the eve CBD oil range. As previously stated, as these oils are sold under a licensing agreement with Sana Lifestyle, eve expects the return will be more from raised brand awareness and the advancement of eve's sleep wellness proposition, rather than revenues and profits. eve has also extended its range of sleep gifting and wellness products in recent weeks, including the non-alcoholic plant based three spirit nightcap drink, the gingko baton low glow night light, a range of eym candles and a selection of rescue remedy products designed to aid a restful night's sleep. In the coming weeks further new products will be launched including a child's version of the very popular Morphee sleep aid and a new long thin hot water bottle. In tandem with the step-up in new product development and introduction, packaging has also been upgraded including the use of fabric bags, for pillows and bedding etc, which are designed to have a second use to further eve's sustainability position. As of today eve now has a product range of over 300 SKU's, of which some 70% are non-mattress products. Cheryl Calverley, CEO of eve Sleep commented: "It takes much more than a wonderful mattress and fabulous bedding to give people the sleep they need to rise and shine, and expanding our range in both consumables and sleep accessories is core to our strategy. These new products offer the opportunity to drive more regular, repeat purchases from existing customers, and increased basket size from new customers, as well as cementing our authority as the only dedicated sleep wellness retailer in the UK."
16/7/2021
06:04
david gruen: 16/07/2021 7:00am UK Regulatory (RNS & others) Eve Sleep plc (EVE) Eve Sleep plc: Trading Update 16-Jul-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- Trading update 13% sales growth in H1, on-course for full year expectations eve Sleep ("eve", the "Company), the direct to consumer sleep wellness brand operating in the UK, Ireland (together "UK &I") and France announces a trading update for the six months ended 30 June 2021. Financial highlights ? Group revenue increased 13% to GBP13.9m (2020: GBP12.2m) ? UK&I revenues increased year-on-year by 18% ? French revenues decreased year-on-year by 8%, as a result of minimal marketing investment in Q1 ahead of the new TV campaign ? Increase in average order values has largely offset intake pricing pressures ? Group marketing contribution and EBITDA losses in line with management's expectations. ? Closing net cash at 30 June 2021 of GBP5.2m (31 December 2020: GBP8.4m) includes GBP0.7m for increased stock holding, repayment of GBP0.3m VAT deferred from Q1 2020 and a seasonal working capital outflow. Strategic and operational highlights ? Launch of major, new French TV campaign 'La vie en jaune' from May ? Further product expansion beyond mattresses including new bed frames, YinYang duvet, bamboo linen bedding, Morphee sleep aid and launch of Sleep Away 'sleepovers' range ? Agreed CBD licensing deal to go live in September as part of product expansion into sleep wellness ? Increased investment in stock to strengthen business resilience and meet peaks in demand ? Appointment of Mike Lloyd as Chairman and Masood Choudhry as Non-Executive Director Good first half performance The UK&I market had a good first half with revenue growth of 18%, notwithstanding more challenging comparatives in the second quarter. Compared with pre pandemic revenues in H1 2019, UK&I sales were 15% higher. Growth was primarily online, with a softer performance from retail partners, reflecting lock down restrictions over the first quarter and to some extent the permanence of channel shift to ecommerce. Demand was particularly strong for eve's hybrid mattress range and premium bed frames, with accessories such as the morphee sleep aid and the weighted blanket, and add-ons such as the temperature balancing protector driving materially higher basket values. eve continues to benefit from the Which? survey which rated eve's original and its premium hybrid the two best mattresses in the UK, and que choisir which ranks the premium hybrid as the best mattress in France. UK marketing investment was front half weighted, increasing to 29% of revenue (2020 H1: 27%) as a result of increased TV advertising, setting up a strong brand position for trading in the second half of the year. In France the majority of the first half of the year was spent preparing for the launch of the new marketing campaign - 'La vie en jaune', which began in May. Ahead of the new campaign, marketing spend was minimal, resulting in revenues for the period marginally lower year-on-year at GBP2.2m. Investment in French marketing is first half weighted, reflecting upfront development costs and was approximately GBP1m in the period. The financial payback on this investment is expected in the second half of the year and over 2022. Early indications from June suggest that the marketing campaign has been well received, with a strong increase in online traffic. Second half outlook Whilst visibility on UK trading conditions for the second half of the year remains limited, the economic recovery looks to be gaining momentum, underpinned by ongoing strength in consumer spending, including on the home. Consumer confidence continues to strengthen and personal savings remain at elevated levels, with fears of mass unemployment abating. These positive demand factors bode well for the retail sector and eve, and as yet the business has seen no signs of a return to pre pandemic shopping behavior, suggesting the online momentum continues. However, the future path of the pandemic is unclear and the risk of further shocks and disruption to the economic recovery remains. As previously set-out in eve's final results on 18 March 2021 there has been some industry supply challenges around raw material inflation and componentry shortages. As expected at the time of the results these pressures have since abated to some degree, and in terms of componentry issues, eve has managed this through the investment in additional stock to ensure customers receive a first-rate service. There may well be further disruption and inflationary pressures, dependent on how the pandemic continues to affect global supply chains. Management anticipate second half revenues in line with expectations and minimal cash outflows. The Company plans to publish its interim results on 23 September 2021. Cheryl Calverley, CEO of eve Sleep commented: "First half revenue growth of 13% is a pleasing result, and in line with our expectations. Our UK business is up 15% on pre pandemic revenue levels reported in H1 of 2019. The balance across sales channels has shifted somewhat, but the overall business is in good health. The start of our investment programme in France has been very encouraging, and we look forward to seeing this campaign power our business performance over the next two years, replicating the progress we have seen in the UK. Maintaining excellent customer service in the face of fluctuating demand and supply chain challenges has been a core focus for us, and the decisions we have taken to improve the resilience of our business through increasing our stock holding and investing in our operational and people capability have undoubtedly underpinned the good H1 performance. We enter the second half of the year with confidence."
21/1/2021
08:30
katsy: EVE Live PriceLast checked at 08:30:12 Eve Sleep plc: Trading Statement Thu, 21st Jan 2021 07:00 Eve Sleep plc (EVE) Eve Sleep plc: Trading Statement 21-Jan-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. This announcement contains inside information Trading update 18% sales growth in H2, exceeded twice raised expectations for 2020 eve Sleep ("eve", the "Company), the direct to consumer sleep wellness brand operating in the UK, Ireland (together "UK&I") and France announces a trading update for the full year ended 31 December 2020. All figures remain subject to audit. Strategic and operational highlights Winner of the best two mattresses in the UK according to Which? and 3 of the top 5 Extended the sleep wellness ranges with new bedframes, sleep gifts and bedding Entry into sleep gifts market with launch of 'well slept' range online and in partnership with Boots UK seeing strong success Launched retail partnership in France with Olivier Desforges Re-platformed the UK&I websites to Shopify, with the French website also completed post year end, to secure a more stable, scalable and lower maintenance website Upgraded supply chains to localise manufacturing for both markets ahead of Brexit Restructure of warehousing and distribution to allow shipments to customers to be consolidated into one delivery, deriving lower costs and better customer experience Invested in new Channel 4 TV campaign 'Switch off with eve sleep' running every Sunday night from early November Financial highlights Revenue increased 6% to £25.2m (2019: £23.8m), driven by 18% growth in H2 Record trading over black Friday period and the first week of the Boxing day sales EBITDA losses cut by 81% to £2.0m (2019: EBITDA loss of £10.7m) Closing net cash at 31 December 2020 of £8.3m (2019: £8m), bolstered by £0.3m of tax payments deferred until after the year end Strong 2020 performance eve has exited 2020 in far better shape than it entered the year and now has a more resilient and efficient technology, logistics and operational platform ready for future growth. Losses have been reduced throughout the year, ahead of initial expectations, through a focus on profitable sales channels and product mix improvements, including taking the decision to exit Amazon UK from September. The Company has also maintained its tight control of overheads and a continued focus on improving marketing efficiency and effectiveness, on a marketing budget, which was 51% lower year-on-year. The focus and driver of the results this year has been the UK business, with the French business being at an earlier stage in its development. The business has undoubtedly benefitted from the accelerated shift to e-commerce and the current strength of the homewares category as a result of the pandemic. A focus on strengthening and widening the product set, with new sleep wellness products including a weighted blanket and the introduction of a sleep gifts range has also given broader brand presence. In addition the business has improved its mattress range resulting in Which? now recognizing eve's original hybrid and premium hybrid as the two best mattresses in the UK - supporting further growth. Together, these factors have driven an 18% year-on-year increase in revenues in the second half of the year, benefitting from the additional UK 'switch off with eve Sleep' TV campaign from November. The strength of trading was evident across the product set, with particular growth in premium products, particularly the Premium Hybrid mattress and the Spindle bedframe. These are two of the highest priced products in the mattress and bed frame ranges, showing the increasing strength of the eve brand. As stated in eve's interim results of 15 September 2020, the industry has experienced some upward pressure on raw material and component pricing, as well as supply constraints due to global chemical shortages. With these inflationary pressures continuing through the fourth quarter eve took the decision in November to put through modest price increases in order to sustain margins. Thanks to the increasing strength of the eve brand, with reducing price elasticity in the more premium products, these price increases have not adversely impacted the rate of sale. Whilst the inflationary impact has been negated for now, supply shortages remained an issue for the industry through the fourth quarter. 2021 trading and outlook Trading in the first few weeks of the year has started well and is following the same positive trends seen in recent months. The availability of raw materials and component supply remains an industry issue and a potential limiting factor on near term growth. At this time the Company has not experienced any material cost/duty increases as a direct result of Brexit, though there has been some slowing of the pace of deliveries to Ireland and Northern Ireland resulting from courier related issues. eve will continue to closely monitor the situation but does not expect any material full year impact at this time. 2021 will be the year eve transitions from the rebuild strategy, which commenced in the second half of 2018, to focus on growth opportunities in the UK and beyond in order to build a stronger, broader and larger, profitable business. Expansion will be managed in a controlled and disciplined manner, with the initial focus for investment on the Company's existing French market. Having already completed the restructuring of the French business and its cost structures, the Company is now ready to invest in both its B2C and retail sales channels, adopting many of the same strategies that have been deployed successfully to scale the UK business, including its first new TV campaign in three years. The investment required to scale the French business will come from the Company's existing cash resources. The Company plans to publish its full year audited results on 18 March 2021. Cheryl Calverley, CEO of eve Sleep commented: "Our business reset is largely complete and our growth has accelerated more quickly than we initially anticipated as a result of the shift to online and the current strength of the homewares market. We have exceeded our financial expectations for 2020, which were raised twice during the year, extended our product ranges, opened new sales channels, increased brand awareness, presence and recognition, with the winning of the Which? awards, and improved the strength and resilience of our technology, logistics and operations platforms. This is entirely down to the tireless dedication, creativity and commitment of our team, who moved seamlessly to home working from March, without the need to furlough staff or make redundancies. I take my hat off to each and every one of them. In 2021 we will invest in growth initiatives across our business, particularly in France, where we see good opportunities to scale, whilst continuing to build on the current UK momentum. We are confident in the near-term outlook and although there is a high level of uncertainty as to the macro-economic backdrop and spending habits of consumers in the second half of the year, we have entered the new financial period with a much improved proposition, a stronger Balance Sheet and a more resilient business."
21/1/2021
08:29
niggle: Reported full year EBITDA loss of £2m - you can read it on LSE Trading update 18% sales growth in H2, exceeded twice raised expectations for 2020 eve Sleep ("eve", the "Company), the direct to consumer sleep wellness brand operating in the UK, Ireland (together "UK&I") and France announces a trading update for the full year ended 31 December 2020. All figures remain subject to audit. Strategic and operational highlights Winner of the best two mattresses in the UK according to Which? and 3 of the top 5 Extended the sleep wellness ranges with new bedframes, sleep gifts and bedding Entry into sleep gifts market with launch of 'well slept' range online and in partnership with Boots UK seeing strong success Launched retail partnership in France with Olivier Desforges Re-platformed the UK&I websites to Shopify, with the French website also completed post year end, to secure a more stable, scalable and lower maintenance website Upgraded supply chains to localise manufacturing for both markets ahead of Brexit Restructure of warehousing and distribution to allow shipments to customers to be consolidated into one delivery, deriving lower costs and better customer experience Invested in new Channel 4 TV campaign 'Switch off with eve sleep' running every Sunday night from early November Financial highlights Revenue increased 6% to £25.2m (2019: £23.8m), driven by 18% growth in H2 Record trading over black Friday period and the first week of the Boxing day sales EBITDA losses cut by 81% to £2.0m (2019: EBITDA loss of £10.7m) Closing net cash at 31 December 2020 of £8.3m (2019: £8m), bolstered by £0.3m of tax payments deferred until after the year end Strong 2020 performance eve has exited 2020 in far better shape than it entered the year and now has a more resilient and efficient technology, logistics and operational platform ready for future growth. Losses have been reduced throughout the year, ahead of initial expectations, through a focus on profitable sales channels and product mix improvements, including taking the decision to exit Amazon UK from September. The Company has also maintained its tight control of overheads and a continued focus on improving marketing efficiency and effectiveness, on a marketing budget, which was 51% lower year-on-year. The focus and driver of the results this year has been the UK business, with the French business being at an earlier stage in its development. The business has undoubtedly benefitted from the accelerated shift to e-commerce and the current strength of the homewares category as a result of the pandemic. A focus on strengthening and widening the product set, with new sleep wellness products including a weighted blanket and the introduction of a sleep gifts range has also given broader brand presence. In addition the business has improved its mattress range resulting in Which? now recognizing eve's original hybrid and premium hybrid as the two best mattresses in the UK - supporting further growth. Together, these factors have driven an 18% year-on-year increase in revenues in the second half of the year, benefitting from the additional UK 'switch off with eve Sleep' TV campaign from November. The strength of trading was evident across the product set, with particular growth in premium products, particularly the Premium Hybrid mattress and the Spindle bedframe. These are two of the highest priced products in the mattress and bed frame ranges, showing the increasing strength of the eve brand. As stated in eve's interim results of 15 September 2020, the industry has experienced some upward pressure on raw material and component pricing, as well as supply constraints due to global chemical shortages. With these inflationary pressures continuing through the fourth quarter eve took the decision in November to put through modest price increases in order to sustain margins. Thanks to the increasing strength of the eve brand, with reducing price elasticity in the more premium products, these price increases have not adversely impacted the rate of sale. Whilst the inflationary impact has been negated for now, supply shortages remained an issue for the industry through the fourth quarter. 2021 trading and outlook Trading in the first few weeks of the year has started well and is following the same positive trends seen in recent months. The availability of raw materials and component supply remains an industry issue and a potential limiting factor on near term growth. At this time the Company has not experienced any material cost/duty increases as a direct result of Brexit, though there has been some slowing of the pace of deliveries to Ireland and Northern Ireland resulting from courier related issues. eve will continue to closely monitor the situation but does not expect any material full year impact at this time. 2021 will be the year eve transitions from the rebuild strategy, which commenced in the second half of 2018, to focus on growth opportunities in the UK and beyond in order to build a stronger, broader and larger, profitable business. Expansion will be managed in a controlled and disciplined manner, with the initial focus for investment on the Company's existing French market. Having already completed the restructuring of the French business and its cost structures, the Company is now ready to invest in both its B2C and retail sales channels, adopting many of the same strategies that have been deployed successfully to scale the UK business, including its first new TV campaign in three years. The investment required to scale the French business will come from the Company's existing cash resources. The Company plans to publish its full year audited results on 18 March 2021. Cheryl Calverley, CEO of eve Sleep commented: "Our business reset is largely complete and our growth has accelerated more quickly than we initially anticipated as a result of the shift to online and the current strength of the homewares market. We have exceeded our financial expectations for 2020, which were raised twice during the year, extended our product ranges, opened new sales channels, increased brand awareness, presence and recognition, with the winning of the Which? awards, and improved the strength and resilience of our technology, logistics and operations platforms. This is entirely down to the tireless dedication, creativity and commitment of our team, who moved seamlessly to home working from March, without the need to furlough staff or make redundancies. I take my hat off to each and every one of them. In 2021 we will invest in growth initiatives across our business, particularly in France, where we see good opportunities to scale, whilst continuing to build on the current UK momentum. We are confident in the near-term outlook and although there is a high level of uncertainty as to the macro-economic backdrop and spending habits of consumers in the second half of the year, we have entered the new financial period with a much improved proposition, a stronger Balance Sheet and a more resilient business." For enquiries, please contact: eve Sleep plc Cheryl Calverley, Chief Executive Officer Tim Parfitt, Chief Financial Officer via M7 Communications LTD finnCap Ltd - Nominated Adviser and Broker Matt Goode / Ed Whiley - Corporate Finance Alice Lane - Equity Capital Markets Tel: +44 (0)20 7220 0500 M7 Communications LTD - PR/IR Mark Reed Tel: +44(0)7903 089 543
Eve Sleep share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
EVE
Eve Sleep
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211127 20:52:29